Arkansas Attorney General Dustin McDaniel is asking the state's highest court to uphold a $1.2 billion fine leveled against Johnson and Johnson and a subsidiary over the marketing of an antipsychotic drug. Full story
A Republican senator renewed his criticism of a government-backed program that hands out cell phones after an undercover video showed vendors helping people obtain the phones even after saying they wanted to sell them for drugs and other items. The video was released by conservative activist James O Full story
DUBLIN (Reuters) - U.S.-based Royalty Pharma has dropped a hostile bid worth up to $8 billion for Elan <ELN.I>, leaving the Irish drug maker free to seek other suitors having put itself up for sale last week. Full story
Among the stock activity stories for Monday, June 17, from AP Business News: Full story
The FTC can challenge deals to keep generic drugs off the market, reports CNBC's Hampton Pearson.
Drug developer Theravance Inc. plans to split into two independent, publicly traded companies after a royalty agreement it had ironed out with Irish drugmaker Elan Corp. PLC fell through. Full story
Toure explains how the surveillance state started far before 9/11 - and it started with the way the war on drugs was waged.
Rachel Maddow relays the details of a CBS News report that investigations into scandalous and/or illegal behavior by members of the State Department are being suppressed, leading to preliminary reports being leaked to the press.
CNBC's Jackie DeAngelis reports on drug companies making headlines out of the ASCO conference. David Risinger, Morgan Stanley, discusses the rise in melanoma treatments shown at this year's event.
Oklahoma Bureau of Narcotics spokesman Mark Woodward reveals that “the plane... the plane” from the hit TV show “Fantasy Island” was used to smuggle drugs from Colombia into United States after the show finished produuction in 1983. KFOR’s Lance West reports.
Experimental drugs give a Tennessee girl born without bones a new lease on life. WSMV's Terry Bulger reports.
The British government's former chief drugs adviser, David Nutt, reacts as he speaks during a news conference announcing the formation of the Independent Scientific Committee on Drugs, in London January 15, 2010. REUTERS/Suzanne Plunkett
Injection-pens of the diabetes drug Lantus SoloStar are pictured at a manufacturing site of French drugmaker Sanofi in Frankfurt June 5, 2013. To keep its no. 2 spot in the $43 billion-a-year diabetes market, Sanofi is testing an improved version of Lantus, a synthetic insulin developed at the Frank
Agent ampoules of the diabetes drug Lantus SoloStar are sorted at a manufacturing site of French drugmaker Sanofi in Frankfurt June 5, 2013. To keep its no. 2 spot in the $43 billion-a-year diabetes market, Sanofi is testing an improved version of Lantus, a synthetic insulin developed at the Frankfu
An employee sorts agent ampoules of the diabetes drug Lantus SoloStar at a manufacturing site of French drugmaker Sanofi in Frankfurt June 5, 2013. To keep its no. 2 spot in the $43 billion-a-year diabetes market, Sanofi is testing an improved version of Lantus, a synthetic insulin developed at the
